One sentence summary: The proteome of an intracellular pathogen Ehrlichia chaffeensis becomes aggregation-prone during infection of mammalian cells. Editor: Akio Nakane
INTRODUCTION
Upon infection of a host, pathogens experience stress, including heat shock and oxidative stress, and their survival depends on molecular responses that help them adjust to the external conditions. The role of stress response in host-pathogen interactions is emerging as a novel direction in studies on the mechanisms of infection (Stewart and Young 2004; Henderson, Allan and Coates 2006; Neckers and Tatu 2008) , but the effects of host-induced stress on the quality of pathogen proteins have not been fully investigated.
Ehrlichia chaffeensis, a member of the Anaplasmataceae family, is an intracellular rickettsial bacterium transmitted from an infected tick, Amblyomma americanum, to humans and several other vertebrate hosts (Paddock and Childs 2003; Walker, Paddock and Dumler 2008) . This pathogen is responsible for causing human monocytic ehrlichiosis, a condition that can progress to a fatal outcome, particularly in elderly, immunecompromised individuals and in children (Paddock and Childs 2003) .
We have previously demonstrated that a molecular chaperone ClpB is upregulated in E. chaffeensis during its replication inside infected mammalian cells (Zhang et al. 2013) . ClpB belongs to the AAA+ family of ATPases associated with different cellular activities, a group of energy-dependent conformationremodeling factors (Neuwald et al. 1999; Hanson and Whiteheart 2005) . In bacteria, yeast and plants, ClpB (also known as Hsp104 or Hsp101) is an essential factor for survival under heat shock (Squires et al. 1991; Lindquist and Kim 1996; Hong and Vierling 2001) . Unlike other molecular chaperones, ClpB is not found in animals and humans. ClpB cooperates with the members of Hsp70 and Hsp40 chaperone families in resolubilization and reactivation of aggregated proteins that accumulate in cells under conditions of stress (Zolkiewski, Zhang and Nagy 2012; Mogk, Kummer and Bukau 2015) . ClpB supports virulence and survival of a number of bacterial and protozoan pathogens including Staphylococcus aureus (Frees et al. 2004) , Pseudomonas aeruginosa (Lehoux, Sanschagrin and Levesque 2002) , Salmonella typhimurium (Turner et al. 1998) , Shigella dysenteriae (Pieper et al. 2009; Kuntumalla et al. 2011) , Porphyromonas gingivalis (Capestany et al. 2008) , Mycoplasma pneumoniae (Kannan et al. 2008) , Francisella tularensis (Meibom et al. 2008) , Enterococcus faecalis (de Oliveira et al. 2011) , Mycobacterium tuberculosis (Estorninho et al. 2010; Vaubourgeix et al. 2015) , Leptospira interrogans (Lourdault et al. 2011) , Leischmania donovani (Krobitsch and Clos 1999) and Plasmodium falciparum (Beck et al. 2014; Elsworth et al. 2014) . These established links between ClpB and the infectivity and survival of multiple different pathogens suggest that host-induced stress can result in misfolding and aggregation of pathogen's proteins and that their functional restoration can be mediated by ClpB. However, no studies of the folding status of pathogens' proteomes during the infectious stages of their life cycles have been performed so far.
In this study, we investigated the levels of protein aggregation in E. chaffeensis during infection of mammalian cells and a possible role of ClpB in controlling protein aggregation. We discovered that a loss of the ClpB activity correlates with an increase in the amount of aggregated proteins in the pathogen and with a dramatic drop in the pathogen's capability to proliferate in the infected cells. We provide the first demonstration of a link between in-host survival of an intracellular bacterial pathogen and its protein quality control.
MATERIALS AND METHODS

In vitro cultivation of Ehrlichia chaffeensis in mammalian cells
Ehrlichia chaffeensis was cultivated in canine macrophage cell line DH82 from ATCC (Catalog # CRL-10389). The culture medium consisted of 500 ml minimum essential medium with Earle's salt, 6 ml 200 mM L-glutamine and 35 ml heat-inactivated fetal bovine serum (Gibco/Thermo Fisher Scientific, Waltham, MA, USA). Cells were incubated at 37
• C with 5% CO 2 . Confluent healthy DH82 cells in a T150 flask were inoculated with cell-free macrophage culture-derived Arkansas isolate of the E. chaffeensis infectious form. In some experiments, the cultures were supplemented with 0.25 or 0.5 mM guanidinium chloride (GuHCl). At specific time intervals, the 25-ml cultures were used for E. chaffeensis purification and analysis of protein aggregation. Infection status of each culture was checked by hematoxylin staining (Cheng and Ganta 2008) .
Purification of Ehrlichia chaffeensis from infected mammalian cells
Infected cells at various times post inoculation were harvested with a cell scraper and collected by centrifugation at 500 g for 5 min at 4
• C. The supernatant was retained and the pellet was resuspended in 1× sterile DPBS (Dulbecco Phosphate Buffer Saline, Invitrogen/Thermo Fisher Scientific, Waltham, MA, USA).
The collected mammalian cells were lysed by passing through a sterile 23.5-G needle 15 times followed by centrifugation at 500 g for 5 min at 4
• C. The resulting supernatant was combined with the one obtained in the first step and the total sample was filtered using 2.7 μm sterile syringe filters. The filtered supernatant was centrifuged at 15 000 g for 15 min at 4
• C. The resulting pellet was resuspended in 2 ml of sterile 1× DPBS, placed on top of 5 ml 30% Renografin MD-76 layer (Mallinckrodt Pharmaceuticals, St. Louis, MO, USA), and centrifuged at 100 000 g for 1 h at 4
• C. The pellet was suspended in 1× DPBS and the purified E. chaffeensis cells were collected by centrifugation at 15 000 g for 15 min.
Isolation of protein aggregates
To isolate protein aggregates, E. chaffeensis cells were lysed by sonication as described previously (Kwiatkowska et al. 2008) . The sample volume was adjusted to normalize for the number of bacterial cells in each sample. To determine the numbers of E. chaffeensis cells, the levels of 16S rDNA were measured with TaqMan probe-based PCR assay, as described before (Sirigireddy and Ganta 2005) . After the removal of unbroken bacterial cells by centrifugation (15 min, 2000 g), the supernatant was incubated with 2% Triton X-100 for 30 min at room temperature. Subsequently, insoluble aggregates were pelleted after 30-min centrifugation at 21 000 g. The remaining supernatant was collected for analysis as the soluble fraction. The protein concentration of the aggregated and soluble fractions, and the whole cell extracts was measured with BCA reagent (Thermo Fisher Scientific, Waltham, MA, USA).
SDS-PAGE and western blotting
Protein analysis with SDS-PAGE and western blotting were performed using standard methods (Sambrook, Fritsch and Maniatis 1989) . ClpB was detected using the polyclonal rabbit antisera raised against a recombinant E. chaffeensis ClpB (Zhang et al. 2013) 
ClpB ATPase activity
Recombinant E. chaffeensis ClpB was produced in Escherichia coli and purified as described before (Zhang et al. 2013) . ClpB (0.02 mg/ml) was incubated in the assay buffer (50 mM Tris/HCl pH 7.5, 50 mM KCl, 1 mM DTT, 1 mM EDTA, 10 mM MgCl 2 and 5 mM ATP) at 37
• C for 15 min without or with GuHCl (see Fig. 2A ). The concentration of phosphate generated by the enzymatic activity of ClpB was measured as described before (Zolkiewski 1999 ).
Ehrlichia chaffeensis survival assay
Varying concentrations of GuHCl (0-2.5 mM) were added to the culture media for the uninfected and E. chaffeensis-infected DH82 cells. The host cell growth was monitored for 4 days by cell counting. In parallel, the bacterial growth was determined by real-time PCR targeting 16S rDNA gene (Sirigireddy and Ganta 2005) .
RESULTS AND DISCUSSION
The previously observed upregulation of clpB mRNA in Ehrlichia chaffeensis during infection of mammalian cells (Zhang et al. 2013) suggests an infection-linked demand for the protein disaggregating chaperone. We asked if the amount of aggregated proteins in E. chaffeensis increases during its replication inside the infected mammalian cells. We purified E. chaffeensis cells from the infected macrophages and then isolated the insoluble protein fraction from the total bacterial lysate at different times post the macrophage infection (Fig. 1) . The protein pattern in the aggregated fraction (Fig. 1A) was distinct from that of the total lysate (Fig. 1B) , which indicates that the aggregation affects a subset of E. chaffeensis proteins. Importantly, a fraction of the total bacterial protein content that was found in the aggregated state increased until 48 h post infection and declined thereafter (Fig. 1C) . The observed increase in the extent of protein aggregation in E. chaffeensis cells occurred during the time of intense pathogen replication and the extent of protein aggregation declined when the pathogen transformed into the non-replicating form (Rikihisa 2010 ). The 48-h post-infection window also coincided with the elevated mRNA levels of clpB (Zhang et al. 2013) . We conclude that infection of mammalian cells and the bacterial replication in the host cells may expose E. chaffeensis to environmental stress that destabilizes a number of its proteins leading to an increased protein aggregation.
To investigate a role of ClpB in supporting the E. chaffeensis proliferation in infected mammalian cells, we employed the only known small-molecule inhibitor of ClpB, guanidinium chloride (GuHCl) (Zolkiewski 1999; Grimminger et al. 2004) . When applied at molar concentrations, GuHCl induces denaturation of many proteins and 6 M GuHCl is often used to dissolve insoluble aggregates. At the millimolar concentrations, GuHCl is too dilute to induce protein denaturation, but at this concentration, the guanidinium cation specifically binds near the N-terminal nucleotide site of ClpB and inhibits the ATP turnover by decreasing the rate of nucleotide dissociation (Zeymer et al. 2013) . Indeed, the rate of ATP hydrolysis catalyzed by ClpB from E. chaffeensis was significantly inhibited by 1 and 10 mM GuHCl (Fig. 2A) .
We asked if the GuHCl-induced partial inhibition of the ClpB ATPase has consequences for survival of E. chaffeensis in infected mammalian cells. As shown in Fig. 2B , up to 0.5 mM GuHCl had no impact on the host cell replication, whereas the E. chaffeensis numbers were reduced by about 60%. The pathogen proliferation was nearly abolished above 0.5 mM GuHCl; however, at that concentration GuHCl also had an influence on the host cell viability. We also assessed the changes in the amount of aggregated proteins in E. chaffeensis cells upon treatment with GuHCl ( Fig. 2C  and D) . Strikingly, we observed a 2-fold increase in accumulation of protein aggregates in E. chaffeensis 48 h post infection of macrophages incubated with 0.5 mM GuHCl. Thus, an apparent inhibition of the proliferation of E. chaffeensis upon treatment with submillimolar GuHCl (see Fig. 2B ) may be due to a loss of activity of multiple bacterial proteins that accumulate as aggregates in the pathogen's cells as the result of ClpB inactivation. Previous studies demonstrated that the GuHCl-induced prion-disaggregation deficiency in yeast is specifically mediated by interaction of the guanidinium cation with ClpB (Saccharomyces cerevisiae Hsp104) (Jung, Jones and Masison 2002) . Thus, it is likely that ClpB is also the main target of GuHCl in E. chaffeensis and its inhibition is responsible for the observed increase in the intracellular protein aggregation (see Fig. 2D ). Interestingly, an apparent inhibition of E. chaffeensis growth in mammalian cells occurred at the GuHCl concentration that was lower than that required for a complete inhibition of the ClpB ATPase (compare Fig. 2A and B) . Possibly, even partial inhibition of ClpB is sufficient for compromising protein homeostasis in E. chaffeensis cells under host-induced stress.
We used immunoblotting to track the accumulation of ClpB in E. chaffeensis during the pathogen proliferation in macrophages (Fig. 3) . We observed a significant increase in the total amount of ClpB up to 48 h post infection, which agreed with the previously reported upregulation of the clpB transcript (Zhang et al. 2013) . Whereas the majority of ClpB remained soluble under normal growth conditions, 0.5 mM GuHCl induced an apparent targeting of ClpB to the aggregated protein fraction. The apparent GuHCl-induced shift of ClpB from the soluble to the aggregated fraction of E. chaffeensis proteins was observed as early as 24 h post infection (Fig. 3) , when the aggregation level did not significantly increase (Fig. 2D) . Preferential targeting of ClpB to the aggregated proteins in E. chaffeensis is consistent with ClpB's biological function in controlling protein aggregation (Zolkiewski, Zhang and Nagy 2012) . Moreover, the GuHCl-induced partial inhibition of the ClpB ATPase ( Fig. 2A ) may suppress the rate of dissociation of the chaperonesubstrate complex, effectively trapping ClpB among its aggregated substrates.
To the best of our knowledge, our results demonstrate for the first time a link between the proliferation of an intracellular pathogen in a mammalian host and the activity of a molecular chaperone involved in controlling protein aggregation. As described above, an essential role of ClpB in supporting virulence of a number of pathogenic microorganisms has been well documented. We provide evidence that as E. chaffeensis replicates inside infected mammalian cells, it is exposed to a proteotoxic stress and the solubility of its proteome is compromised. Moreover, we demonstrate that the aggregation of the pathogen's proteins is exacerbated in the presence of a ClpB inhibitor, which suppresses the pathogen survival. Unlike other heat-shock protein families, the ClpB-type chaperones are not found in animals and humans. Our results highlight the role of ClpB in pathogen survival and validate its potential as a target for antimicrobial therapies. 
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